RSV vaccines recommended for adults 65 and up in important regulatory milestone. ... Respiratory syncytial virus infects nearly everyone by age 2 and typically causes cold symptoms.

The US Food and Drug Administration has approved Moderna’s next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

The CDC recommends that everyone 6 months and older gets a flu vaccine every year, including those 50 and up. ... "Together with flu and RSV, ... which called for vaccines in adults 65 and older.

In an update to recommendations from June, in three unanimous votes, ACIP recommended a second dose of the 2024-2025 COVID vaccine for adults ages 65 and older, as well as people ages 6 months to ...

by at least 11% and up to 18%. The CDC advises adults 65 and older to receive the enhanced vaccines, as many already do. More good news: Vaccines to prevent respiratory syncytial virus in people 60 ...

In the 2024 Australian winter period, RSV laboratory-notified cases in adults aged 65 and older were nearly two-thirds the number of influenza cases in the same age group. 2 90% of RSV-related ...

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company said Saturday, the first approval under new regulations.

In an update to recommendations from June, in three unanimous votes, ACIP recommended a second dose of the 2024-2025 COVID vaccine for adults ages 65 and older, as well as people ages 6 months to ...

By Chandni Shah, Mariam Sunny and Christy Santhosh (Reuters) -The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, the ...